Abstract
The binding of fisetin with human serum albumin (HSA) has been studied at different pH using UV-Vis, FTIR, CD and fluorescence spectroscopic techniques. The binding constants were found to increase with the rise in pH of the media. The negative ΔH° (kJ mol-1) and positive ΔS° (J mol-1 K-1) indicate that fisetin binds to HSA via electrostatic interactions with an initial hydrophobic association that result in a positive ΔS°. In presence of potassium chloride (KCl) the binding constants were found to be decrease. The α-helical content of HSA increased after binding with fisetin as analyzed from both CD and FTIR methods. The site marker displacement studies using fluorescence anisotropy suggest that fisetin binds to the hydrophobic pocket (Site 1, subdomain IIA) of HSA which is in good accordance with the molecular docking study. The change in accessible surface area (ASA) of residues of HSA was calculated to get a better insight into the binding.
Keywords: Binding, docking, fisetin, fluorescence and human serum albumin, antioxidant agents, ischemia, atherosclerosis, cardiovascular disease, human mast cells (HMC-1)
Protein & Peptide Letters
Title:Study of the Interaction Between Fisetin and Human Serum Albumin: A Biophysical Approach
Volume: 19 Issue: 6
Author(s): Atanu Singha Roy, Amit Kumar Dinda and Swagata Dasgupta
Affiliation:
Keywords: Binding, docking, fisetin, fluorescence and human serum albumin, antioxidant agents, ischemia, atherosclerosis, cardiovascular disease, human mast cells (HMC-1)
Abstract: The binding of fisetin with human serum albumin (HSA) has been studied at different pH using UV-Vis, FTIR, CD and fluorescence spectroscopic techniques. The binding constants were found to increase with the rise in pH of the media. The negative ΔH° (kJ mol-1) and positive ΔS° (J mol-1 K-1) indicate that fisetin binds to HSA via electrostatic interactions with an initial hydrophobic association that result in a positive ΔS°. In presence of potassium chloride (KCl) the binding constants were found to be decrease. The α-helical content of HSA increased after binding with fisetin as analyzed from both CD and FTIR methods. The site marker displacement studies using fluorescence anisotropy suggest that fisetin binds to the hydrophobic pocket (Site 1, subdomain IIA) of HSA which is in good accordance with the molecular docking study. The change in accessible surface area (ASA) of residues of HSA was calculated to get a better insight into the binding.
Export Options
About this article
Cite this article as:
Singha Roy Atanu, Kumar Dinda Amit and Dasgupta Swagata, Study of the Interaction Between Fisetin and Human Serum Albumin: A Biophysical Approach, Protein & Peptide Letters 2012; 19 (6) . https://dx.doi.org/10.2174/092986612800493995
DOI https://dx.doi.org/10.2174/092986612800493995 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Preclinical Pharmacokinetics: An Approach Towards Safer and Efficacious Drugs
Current Drug Metabolism Design Potential Selective Inhibitors for Treating Cancer by Targeting the Src Homology 2 (SH2) Domain-Containing Phosphatase 2 (Shp2) with Core Hopping Approach
Protein & Peptide Letters Evaluation of Salivary Melatonin Levels in HIV-positive Patients: A Historical Cohort Study
Reviews on Recent Clinical Trials Applications of 211At and 223Ra in Targeted Alpha-Particle Radiotherapy
Current Radiopharmaceuticals Models to Study Atherosclerosis: A Mechanistic Insight
Current Vascular Pharmacology Clinical Management of Oral Lichen Planus: A Systematic Review
Mini-Reviews in Medicinal Chemistry MicroRNA Therapeutics: The Emerging Anticancer Strategies
Recent Patents on Anti-Cancer Drug Discovery Glycobiology of Neural Stem Cells
CNS & Neurological Disorders - Drug Targets The Prodigiosins: A New Family of Anticancer Drugs
Current Cancer Drug Targets Beta-cell Specific Autoantibodies: Are they Just an Indicator of Type 1 Diabetes?
Current Diabetes Reviews Mechanisms of Melatonin in Alleviating Alzheimer’s Disease
Current Neuropharmacology Estrogen Receptors as Therapeutic Targets in Breast Cancer
Current Topics in Medicinal Chemistry Endothelial Cell-Based Methods for the Detection of Cyanobacterial Anti- Inflammatory and Wound-Healing Promoting Metabolites
Drug Metabolism Letters Relevance of CYP2C9 Function in Valproate Therapy
Current Neuropharmacology Cyclooxygenase-2 Biology
Current Pharmaceutical Design Advances in Helper-Dependent Adenoviral Vector Research
Current Gene Therapy One-pot Synthesis of Novel Thiophene Containing Aminonaphthols using Fe<sub>3</sub>O<sub>4</sub> Nanoparticles as a Recyclable Heterogeneous Catalyst
Current Catalysis Candidate Biomarkers for Fatigue in Systemic Lupus Erythematosus: A Critical Review
Current Rheumatology Reviews Preclinical and Clinical Studies on Bryostatins, A Class of Marine-Derived Protein Kinase C Modulators: A Mini-Review
Current Topics in Medicinal Chemistry Inhaled Biologicals for the Treatment of Cystic Fibrosis
Recent Patents on Inflammation & Allergy Drug Discovery